Status | Study |
Recruiting |
Study Name: A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases Condition: Stage IIIC Skin Melanoma Stage IV Skin Me Date: 2016-09-14 Interventions: Drug: nivolumab low fixed dose |
Not yet recruiting |
Study Name: Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma Condition: Cutaneous Melanoma Melanoma Date: 2016-08-02 Interventions: Procedure: Sentinel Lymph Node Biopsy |
Recruiting |
Study Name: A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope) Condition: Breast Cancer Cutaneous Melanoma Date: 2016-07-11 Interventions: Procedure: Blood sampling After inclusion in the protocol, a blood sample (50 mL in EDTA tubes) will be |
Recruiting |
Study Name: Ibrutinib in Treating Patients With Refractory Stage IV Cutaneous Melanoma Condition: Metastatic Melanoma Recurrent Melanoma of the Skin Date: 2015-10-20 Interventions: Drug: Ibrutinib Given PO |
Active, not recruiting |
Study Name: Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients Condition: Stage III Skin Melanoma Date: 2015-04-13 Interventions: Procedure: Surgery of the tumor Drug: Infu |
Active, not recruiting |
Study Name: Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes Condition: Cutaneous Melanoma Date: 2014-12-18 |
Active, not recruiting |
Study Name: 5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results Condition: Cutaneous Melanoma Date: 2014-12-18 |
Recruiting |
Study Name: Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma Condition: Cutaneous Malignant Melanoma Date: 2014-12-02 Interventions: Drug: Nintedanib Nintedanib (1 |
Recruiting |
Study Name: MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma Condition: Cutaneous Melanoma by AJCC V7 Stage Date: 2014-06-13 Interventions: Procedure: Wide Local Excision = 1cm Margin |
Recruiting |
Study Name: Minimal SN Tumor Burden Condition: Cutaneous Melanoma Date: 2013-09-11 |